The role of innate immune factors in acute myeloid leukemia before and after chemotherapy
- 作者: Vinnitskaya A.B.1, Svitich O.A.1,2, Golenkov A.K.3, Klinushkina E.F.3, Zaitseva T.A.2, Davydova N.V.2, Zverev V.V.1,2
-
隶属关系:
- I.I. Mechnikov Scientific Research Institute of Vaccines and Serums
- I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
- M.F. Vladimirsky Moscow Regional Research Clinical Institute
- 期: 卷 7, 编号 4 (2021)
- 页面: 41-47
- 栏目: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288196
- DOI: https://doi.org/10.18565/therapy.2021.4.41-47
- ID: 288196
如何引用文章
详细
关键词
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
Alexandra Vinnitskaya
I.I. Mechnikov Scientific Research Institute of Vaccines and Serums
Email: byzonka@yandex.ru
PhD, junior researcher 105064, Moscow, 5A Maly Kazenny Lane
Oksana Svitich
I.I. Mechnikov Scientific Research Institute of Vaccines and Serums; I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: svitichoa@yandex.ru
MD, professor, corresponding member of RAS, professor of the Department of microbiology, virology and immunology of F.F. Erisman Institute of Public Health; Director 105064, Moscow, 5A Maly Kazenny Lane
Anatoly Golenkov
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Email: golenkov@monikiweb.ru
MD, professor, head of the Clinic of clinical hematology and immunotherapy 129110, Moscow, 61/2 Shchepkina Str
Elena Klinushkina
M.F. Vladimirsky Moscow Regional Research Clinical Institutehead of the Department of clinical hematology and immunotherapy 129110, Moscow, 61/2 Shchepkina Str
Tatyana Zaitseva
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: zaytseva_t_a@staff.sechenov.ru
PhD, senior lecturer of the Department of microbiology, virology and immunology of F.F. Erisman Institute of Public Health 25009, Moscow, 11/10 Mokhovaya Str
Natalya Davydova
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: kaf-microb-pmgmu@yandex.ru
PhD, associate professor of the Department of microbiology, virology and immunology of F.F. Erisman Institute of Public Health 25009, Moscow, 11/10 Mokhovaya Str
Vitaly Zverev
I.I. Mechnikov Scientific Research Institute of Vaccines and Serums; I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
Email: zverev_v_v@staff.sechenov.ru
doctor of biological sciences, professor, academician of RAS, head of the Department of microbiology, virology and immunology of F.F. Erisman Institute of Public Health; scientific director 105064, Moscow, 5A Maly Kazenny Lane
参考
- Lin W.W., Karin M.A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007; 117(5): 1175-83. doi: 10.1172/JCI31537.
- Coussens L.M., Werb Z. Inflammation and cancer. Nature. 2002; 420(6917): 860-67. doi: 10.1038/nature01322.
- Lacalle R.A., Blanco R., Carmona-Rodriguez L. et al. Chemokine receptor signaling and the hallmarks of cancer. Int Rev Cell Mol Biol. 2017; 331: 181-244. doi: 10.1016/bs.ircmb.2016.09.011.
- Chow M.T., Luster A.D. Chemokines in cancer. Cancer Immunol Res. 2014; 2(12): 1125-31. doi: 10.1158/2326-6066.CIR-14-0160.
- Филина А.Б., Свитич О.А., Аммур Ю.И. с соавт. Изучение миграционной способности мононуклеарных и опухолевых клеток относительно TLRs лигандов и CXCL12. Российский иммунологический журнал. 2017; 3: 545-547.
- Филина А.Б., Свитич О.А., Голенков А.К. с соавт. Альтернативные пути активации хемотаксиса клеток острого миелоидного лейкоза. Российский иммунологический журнал. 2019; 2: 596-598.
- Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968; 97: 77-89.
- Cancilla D., Rettig M.P., DiPersio J.F. Targeting CXCR4 in AML and ALL. Front Oncol. 2020; 10: 1672. doi: 10.3389/fonc.2020.01672.
- Ladikou E.E., Chevassut T., Pepper C.J., Pepper A.G. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia. Br J Haematol. 2020; 189(5): 815-25. doi: 10.1111/bjh.16456.
- Kremer K.N., Peterson K.L., Schneider P.A. et al. CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak. J Biol Chem. 2013; 288(32): 22899-914. doi: 10.1074/jbc. M113.449926.
- Drury L.J., Ziarek J.J., Gravel S. et al. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. Proc Natl Acad Sci U S A. 2011; 108(43): 17655-60. doi: 10.1073/pnas.1101133108.
- Zhang Y., Tian L., Zheng Y. et al. C-terminal peptides of chemokine-like factor 1 signal through chemokine receptor CCR4 to cross-desensitize the CXCR4. Biochem Biophys Res Commun. 2011; 409(2): 356-61. doi: 10.1016/j.bbrc.2011.05.047.
- Boehrer S., Ades L., Braun T. et al. Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood. 2008; 111(4): 2170-80. doi: 10.1182/blood-2007-07-100362.
- Nath S., Bhattacharyya J., Sarma P.P. et al. The prognostic impact of epidermal growth factor receptor (EGFR) in patients with acute myeloid leukaemia. Indian J Hematol Blood Transfus. 2020; 36(4): 749-53. doi: 10.1007/s12288-020-01274-z.
- Deangelo D.J., Neuberg D., Amrein P.C. et al. A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia. Leuk Res. 2014; 38(4): 430-34. doi: 10.1016/j.leukres.2013.10.026.
补充文件
![](/img/style/loading.gif)